BioAffinity Historical Income Statement
| BIAFW Stock | USD 0.72 0.03 4.00% |
Historical analysis of BioAffinity Technologies income statement accounts such as Interest Expense of 35.3 K, Gross Profit of 831.2 K or Other Operating Expenses of 11 M can show how well bioAffinity Technologies Warrant performed in making a profits. Evaluating BioAffinity Technologies income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of BioAffinity Technologies's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining BioAffinity Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioAffinity Technologies is a good buy for the upcoming year.
BioAffinity |
About BioAffinity Income Statement Analysis
BioAffinity Technologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to BioAffinity Technologies shareholders. The income statement also shows BioAffinity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
BioAffinity Technologies Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BioAffinity Technologies. It is also known as BioAffinity Technologies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on BioAffinity Technologies income statement and represents the costs associated with goods and services BioAffinity Technologies provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in BioAffinity Technologies financial statement analysis. It represents the amount of money remaining after all of bioAffinity Technologies Warrant operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from BioAffinity Technologies' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into BioAffinity Technologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. At this time, BioAffinity Technologies' Selling General Administrative is fairly stable compared to the past year. Total Revenue is likely to climb to about 2.7 M in 2024, despite the fact that Operating Income is likely to grow to (7.6 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.0M | 2.5M | 37.1K | 35.3K | Depreciation And Amortization | 4.8K | 10.2K | 249.6K | 262.1K |
BioAffinity Technologies income statement Correlations
Click cells to compare fundamentals
BioAffinity Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.